Abstract:BACKGROUND:RAB7A (RAS-related in Brain 7A) is an important member of the RAS oncogene family. However, the correlation between RAB7A and the development and immune infiltration of hepatocellular carcinoma (HCC) has rarely been studied. Here, we studied the role of RAB7A in HCC through bioinformatics analysis, real-world cohort validation, and in vitro experimental exploration.MATERIALS AND METHODS:The RAB7A expression level was analyzed through TCGA, HPA and TISIDB databases. TIMER and TISCH were used to analyze the correlation between RAB7A and tumor immune microenvironment. The expression of RAB7A was detected through real-time PCR and western blotting. The cell proliferation was detected by EdU and CCK8. Wound-healing and transwell assays were used to test the invasion and migration ability. Cell cycle distribution and reactive oxygen species (ROS) content were analyzed by flow cytometry. Identification of epithelial-mesenchymal transition (EMT) was performed by immunofluorescence double staining. Immunohistochemistry (IHC) was used to evaluate the correlation between RAB7A and immune checkpoints.RESULTS:RAB7A is upregulated in most of the tumor types, and the upregulation of RAB7A is associated with a poorer prognosis in many cancers. The results showed that RAB7A was significantly positively correlated with the infiltration of macrophages and cancer-associated fibroblasts (CAFs), but negatively correlated with M2-type macrophages in most tumors. The single-cell atlas also revealed the distribution and proportion of RAB7A in immune cells of HCC. The in vitro experiments suggested that RAB7A was increased in HCC tissue and cell lines. The knockdown of RAB7A inhibited the activation of the PIK3CA-AKT pathway and suppressed the expression of CDK4, CDK6 and CCNA2. Knockdown of RAB7A induced G0/G1 arrest and ROS accumulation in HCC. In addition, overexpression of RAB7A enhanced migration and invasion by inducing EMT. The real-world cohort showed that the expression level of RAB7A was positively correlated with the expression levels of TGFBR1 and PD-L1.CONCLUSIONS:RAB7A may serve as a potential tumor prognostic and immune infiltration-related biomarker, predicting immunotherapy efficacy in certain cancer types, especially in HCC. Besides, RAB7A was a multi-pathway target involved in the malignant progression of HCC.

Retinoic Acid Induced 16 Enhances Tumorigenesis and Serves As A Novel Tumor Marker for Hepatocellular Carcinoma

ROR-α-1 Inhibits the Proliferation, Invasion, and Migration of Hepatocellular Carcinoma MHCC97H Via Downregulation of Chemokine CXCL5.

Clinical significance and function of RDH16 as a tumor-suppressing gene in hepatocellular carcinoma

MicroRNA-145 Suppresses Hepatocellular Carcinoma by Targeting IRS1 and Its Downstream Akt Signaling.

Lipophagy-related Gene RAB7A is Involved in Immune Regulation and Malignant Progression in Hepatocellular Carcinoma.

Downregulated Lncrna DRAIC Enhances the Radiotherapy Sensitivity of Human HCC Cell Line HepG2 by Targeting Mir-223-3p

Microrna-155-5p Promotes Hepatocellular Carcinoma Progression by Suppressing Pten Through the Pi3k/Akt Pathway

MiR-146a Enhances Angiogenic Activity of Endothelial Cells in Hepatocellular Carcinoma by Promoting PDGFRA Expression.

Upregulation of amphiregulin by retinoic acid and Wnt signalling promotes liver cancer cell proliferation

MicroRNA-30a Suppresses Tumor Progression by Blocking Ras/Raf/MEK/ERK Signaling Pathway in Hepatocellular Carcinoma.

Downregulation of RAI14 inhibits the proliferation and invasion of breast cancer cells.

RNA-binding motif protein 28 enhances angiogenesis by improving STAT3 translation in hepatocellular carcinoma

Elevation of Mir-191-5p Level and Its Potential Signaling Pathways in Hepatocellular Carcinoma: a Study Validated by Microarray and In-House Qrt-Pcr with 1,291 Clinical Samples.

Targeting to the non-genomic activity of retinoic acid receptor-gamma by acacetin in hepatocellular carcinoma

Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor

MicroRNA-155 Promotes Tumor Growth of Human Hepatocellular Carcinoma by Targeting ARID2.

Biological and clinical implications of retinoic acid-responsive genes in human hepatocellular carcinoma cells

Epigenetic modification of MiR-429 promotes liver tumour-initiating cell properties by targeting Rb binding protein 4.

MicroRNA-616 promotes the migration, invasion and epithelial-mesenchymal transition of HCC by targeting PTEN.

RAB10 Overexpression Promotes Tumor Growth and Indicates Poor Prognosis of Hepatocellular Carcinoma.

MicroRNA-19a-3p Regulates Cell Growth Through Modulation of the PIK3IP1-AKT Pathway in Hepatocellular Carcinoma.